longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Building a "Vertical Growth Pole" for the Building Economy, Shanghai Suhe Bay generated tax revenue of 1 billion yuan from 20 buildings last year

Wallstreetcn
Mar 13, 2025 at 04:52 AM

On March 11, the Shanghai Jing'an Suhe Bay Functional Area 2025 Cooperation Development Conference and Integrated Investment Promotion Service Work Meeting was held. By the end of 2024, the Shanghai Jing'an Suhe Bay has accumulated a total of 11,720 enterprises, with 1,160 new market entities added. In the past two years, 551 enterprises have continuously expanded in scale; there are 22 multinational regional headquarters or headquarters-type enterprises in the area, including Astrazeneca, Pfizer, Da Bang Management, and Vale, which have settled in key buildings of the functional area. The headquarters cluster and industrial gradient coexist, and ecological collaboration attracts more upstream and downstream enterprises to settle in. (The Paper)

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…
  • Jul 29, 2025 at 07:44 AMStrong sales of anti-cancer drugs, AstraZeneca's Q2 revenue increased by 12% year-on-year, exceeding expectations | Fina…

Related Stocks

AstraZeneca

AstraZeneca

USAZN

+1.72%

Vale SA

Vale SA

USVALE

LongbridgeAI